People: Pressure Biosciences Inc (PBIO.PK)

PBIO.PK on OTC Markets Group

0.36USD
17 May 2013
Price Change (% chg)

$-0.02 (-5.26%)
Prev Close
$0.38
Open
$0.36
Day's High
$0.36
Day's Low
$0.36
Volume
5,700
Avg. Vol
35,703
52-wk High
$0.63
52-wk Low
$0.15

Search Stocks

Lawrence, Nathan 

Brief Biography

Dr. Nathan P. Lawrence, Ph.D., is Vice President - Marketing of Pressure BioSciences, Inc. He was appointed as Vice President of Marketing and Sales on April 1, 2006. Dr. Lawrence joined Pressure BioSciences Inc. in 2005, serving as Director of Research and Development until his promotion to Vice President of Marketing in 2006. Dr. Lawrence was responsible for the development of protocols based on Pressure Cycling Technology (PCT). From 2004 through 2005, Dr. Lawrence worked for 454 Life Sciences Inc., in product development. Prior to 454 Life Sciences, Dr. Lawrence was Director of Research and Development for Boston Biomedica, Inc. from 1998 to 2004. He was primarily responsible for the development of PCT, as well as the development of nucleic acid-based diagnostic assays. Prior to joining Boston Biomedica, Inc., Dr. Lawrence held several positions with increasing responsibility in Research and Development and manufacturing at Becton Dickinson and Gene Trak Systems. Dr. Lawrence holds a BA from the University of Miami, an M.S. from Southern Connecticut State University, and a Ph.D. from Yale University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
146,495 -- 1,627 180,825

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Jeffery Peterson

--

Richard Schumacher

328,640

Conrad Mir

--

Edmund Ting

210,773

Nathan Lawrence

180,825

Alexander Lazarev

190,936
As Of 30 Dec 2011
Search Stocks